FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

The company's first year sales came to a total of US $2000 ... with diabetes, and Perclose, a leading vascular closure devices company, marking the company's entry into vascular care.

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

In recent years, smartwatches and smart rings have grown increasingly popular, adorning the wrists and fingers of consumers who use them to monitor their exercise, sleep and heart activity.

Abbott's FreeStyle Libre Report: The Power of Positive Motivation for Type 2 Diabetes Management explores the experiences of Canadians with type 2 diabetes and the factors influencing their care.

The research indicates that 1 in 10 think they've been refused a date because of health issues such as Type 2 diabetes.